Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Science & Co
CoreAge Rx and Science & Co both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxScience & Co
Ranked #16 · Grade C
Best for: Someone already confident of staying the course a year, who wants the discounted rate with the commitment spelled out rather than buried.
Visit Science & CoThe verdict
CoreAge Rx edges out Science & Co on the Rx-Readiness Score, 95 to 79 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Science & Co is still a genuine option — it shows both prices at once and says which is which: $149/mo with no commitment, $79 on a twelve-month plan. Brand-name is listed, but all three pages say coming soon. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Science & Co |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 79/100 · C |
| Overall rank | #1 | #16 |
| Semaglutide | $99/mo | $149/mo |
| Tirzepatide | $149/mo | $199/mo |
| Coverage | All 50 states | All 50 states and Washington, D.C., per its terms |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Science & Co
Ranked #16 · Grade C
What we like
- It publishes the month-to-month price and the long-plan price together, with the saving shown
- It says in its own copy that the low figure is the twelve-month plan
- A five-minute online quiz with no scheduled call in the published flow
The caveats
- The advertised figures are twelve-month plan rates, not monthly ones
- Zepbound, Wegovy and Ozempic each have a page and all three say coming soon
- The microdose, the gentlest entry, is also still coming soon
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Science & Co against other providers on our shortlist.
Or browse the full comparison hub.